NXGL NexGel Inc

NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, is scheduled to participate in the following October 2024 investor conferences.

Maxim’s Healthcare Virtual SummitDate: October 15-17, 2024Presentation Format: Fireside Chat with Naz Rahman, Vice President, Biotechnology AnalystDay and Time: Tuesday, October 15th at 9:30 a.m. ETWebcast: https://ir.nexgel.com/news-events/events-presentations

LD Micro Main Event XVII Conference Details: Date: October 28-30, 2024Location: Luxe Sunset Boulevard Hotel, Los Angeles, CA Presentation Day and Time: Wednesday, October 30th at 11:30 a.m. PT Presentation Location: Track 4 Webcast: https://ir.nexgel.com/news-events/events-presentations

To schedule a one-on-one investor meeting with Mr. Levy, please contact your representatives at Maxim and LD Micro or email KCSA Strategic Communications at NEXGEL@KCSA.Com.

About NEXGEL, Inc.

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contacts:Valter Pinto, Managing DirectorKCSA Strategic Communications212.896.1254NEXGEL@KCSA.Com